2.0
Feb 11, 2019
Recommend
CEO approval
Business Outlook
Pros
GSK pays very well with great benefits
Cons
Directionless with soft targets or unclear objectives Be careful when you speak up, as you will be unofficially classified as an undesirable. Emma has a tough rough as she is starting with R&D but then the rest of the company has some major contention. A lot of push/pull of new vs old way of executing. Generally not a healthy place to be at this time from a career perspective. Be very careful on coming here the sharks are swimming